TRB Chemedica International
Switzerland - GenevaBiotechnology
Focus: TRB Chemedica International is a Switzerland-based biotechnology company specializing in APIs and hyaluronic acid products, with a focused portfolio in ophthalmology and osteoarthritis.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About TRB Chemedica International
AI assessmentNot HiringNo open roles listed right now. Follow TRB Chemedica International to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
BUFY01
Early Development
Novel single-dose container formulation for a high-prevalence ophthalmology indication with limited commercial data available.
BUFY02
Early Development
Help build intelligence for TRB Chemedica International
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.